Pharsight

IONIS PHARMACEUTICALS INC PATENTS FACING OPPOSITIONS

Top patents of IONIS PHARMACEUTICALS INC facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2701713B1 07 Feb, 2018 Modulation Of Apolipoprotein Ciii (Apociii) Expression Apr, 2032 2
EP2399588B1 29 Apr, 2020 Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase Jan, 2022 1
EP3031920B1 21 Aug, 2019 Modulation Of Dystrophia Myotonica-Protein Kinase (Dmpk) Expression Jul, 2031 1